Search Results (593)

Melasma is an acquired hyperpigmentation that is more common in women and mainly affects the face. It can significantly reduce quality of life due to its chronic nature and resistance to treatment. Objectives: This study aimed to compare the clinical efficacy of azelaic acid peeling and combined tranexamic acid microneedling in patients with melasma, evaluating the impact of these therapies on skin depigmentation. Methods: This was a prospective clinical trial with a split-face design, using a convenience sample. Patients were recruited and divided into two groups for comparative treatment. Microneedling with 4 mg/mL tranexamic acid was applied to the right hemiface and 30% azelaic acid peeling to the left hemiface. The protocol included five sessions with a 15-day interval. Photographic records were taken before treatment, in the fifth session, and 15 days after the last session. The Melasma Area and Severity Index (MASI) and non-parametric tests were used to analyze the results. Results: The study included 10 patients, of whom 9 completed the treatment. The average age was 42 years. The most common skin phototype was type III (50%) and the predominant locations were the central facial area, forehead, and cheeks (55.6%). The photographic evaluation and MASI showed a significant improvement on both sides of the face, with the final values better than the initial ones. It was possible to observe that the azelaic acid peeling showed a significant whitening after the fourth session when compared to the other method. Conclusions: The clinical study of hemifaces concluded that both the azelaic acid peeling and microneedling with tranexamic acid are effective in the treatment of melasma, with the azelaic acid peeling showing results after the fourth session. Further studies with larger, randomized samples are recommended. Full article

Continuous monitoring of glucose (CGM) level is of utmost importance to diabetic patients, especially with no or minimal pain. Microneedle arrays with desired electrode patterns have been fabricated by soft lithographic molding, and the patterned electrodes were formed via shadow evaporation through a shadow mask that was made from a modified molding technique. With immobilization of glucose oxidase (GOx), the microneedle electrode arrays (MEAs) have been successfully employed for the in vitro CGM using impedance spectroscopy. The fabricated MEAs could monitor the varying glucose level continuously for up to ~10 days. Similar processes have been applied for the fabrication of stretchable MEAs, which can conform to complex curvilinear surfaces. The simple and low-cost fabrication of MEAs, either in flexible or stretchable forms, may find various applications in wearable health monitoring techniques. Full article

For monitoring animal adaptation when facing environmental challenges, and more specifically when addressing the impacts of global warming—particularly responses to heat stress and short-term fluctuations in osmotic regulations in the different organs influencing animal physiology—there is an increasing demand for digital tools to understand and monitor a range of biomarkers. Microneedle arrays (MNAs) have recently emerged as promising devices minimally invasively penetrating human skin to access dermal interstitial fluid (ISF) to monitor deviations in physiology and consequences on health. The ISF is a blood filtrate where the concentrations of ions, low molecular weight metabolites (<70 kDa), hormones, and drugs, often closely correlate with those in blood. However, anatomical skin differences between human and farm animals, especially large animals, as well as divergent tolerances of such devices among species with behavior specificities, motivate new MNA designs. We addressed technological challenges to design higher microneedles for farm animal (pigs and cattle) measurements. We designed microneedle arrays composed of 37 microneedles, each 2.8 mm in height, using dextran-methacrylate, a photo-crosslinked biocompatible biopolymer-based hydrogel. The arrays were characterized geometrically and mechanically. Their abilities to perforate pig and cow skin were demonstrated through histological analysis. The MNAs successfully absorbed approximately 10 µL of fluid within 3 h of application. Full article

Currently, flexible sensors based on electrochemical principles are predominantly limited to single-parameter detection, making it challenging to meet the demand for synchronous monitoring of multiple analytes in complex physiological environments. This study presents a 3D-printed flexible sensor for synchronous glucose/pH detection. Glucose was quantified via H₂O₂ oxidation current (GOD-catalyzed reaction), while pH was measured through polyaniline (PANI) resistance changes. The ionogel-based microneedle electrode ensures mechanical robustness. At 0.2 V, optimal signal decoupling was achieved: glucose oxidation current dominates, while PANI’s polarization effect is minimized. Neutral pH minimally affected glucose oxidase (GOD) activity, and low glucose concentrations induced negligible pH interference, ensuring orthogonality. In artificial interstitial fluid, the sensor showed glucose: linear response (0.5–2.5 g·L⁻¹, 0.288 μA·mM⁻¹·cm⁻²); pH: piecewise-linear sensitivity (0.155 Ω/pH·cm² for pH > 7; 0.135 Ω/pH·cm² for pH < 7). The design enables real-time multiparameter monitoring with high selectivity, addressing current limitations in flexible electrochemical sensors. Full article

Background/Objectives: Lidocaine is a widely used local anesthetic, but injections and topical creams are often painful or slow in onset. This study aimed to develop dissolving microneedles incorporating lidocaine hydrochloride for rapid and convenient local anesthesia. Methods: Six formulations were prepared with polyvinylpyrrolidone (PVP) and polyvinyl alcohol (PVA) and evaluated for mechanical strength, skin insertion, drug release, and transdermal permeability. Results: Sharp pyramidal microneedles were successfully fabricated, with PVP–PVA mixtures producing stronger needles than single polymers. The optimized F5 formulation showed high strength (>32 N), efficient skin insertion (four parafilm layers), and rapid release (>80% within 15 min). In ex vivo studies, F5 delivered >600 µg/mL lidocaine in 15 min, over three times the therapeutic level and much faster than Emla cream (5%). Conclusions: PVP–PVA microneedles represent a promising platform for painless, rapid local anesthesia, combining the benefits of injections and topical creams while minimizing their drawbacks. Full article

Background/Objectives: Diabetes mellitus (DM) is an increasingly prevalent endocrine disorder affecting humans and companion animals. Type 1 DM (T1DM) and type 2 DM (T2DM) are well characterized in humans, and canine DM most often resembles T1DM, marked by insulin dependence and β-cell destruction. Conversely, feline DM shares key features with human T2DM, including insulin resistance, obesity-related inflammation, and islet amyloidosis. This review provides a comprehensive comparative analysis of antidiabetic therapies in humans, dogs, and cats, focusing on three core areas: disease pathophysiology, pharmacological and delivery strategies, and translational implications. In human medicine, a wide array of insulin analogs, oral hypoglycemic agents, and incretin-based therapies, including glucagon-like peptide-1 receptor agonists (liraglutide) and sodium-glucose cotransporter-2 inhibitors (empagliflozin), are available. Veterinary treatments remain limited to species-adapted insulin formulations and off-label use of human drugs. Interspecies differences in gastrointestinal physiology, drug metabolism, and behavioral compliance influence therapeutic efficacy and pharmacokinetics. Recent innovations, such as microneedle patches for insulin delivery and continuous glucose monitoring systems, show promise in humans and animals. Companion animals with naturally occurring diabetes serve as valuable models for preclinical testing of novel delivery platforms and long-acting formulations under real-world settings. While these technologies show potential, challenges remain in regulatory approval and behavioral adaptation in animals. Conclusions: Future research should prioritize pharmacokinetic bridging studies, veterinary-specific formulation trials, and device validation in animal models. By highlighting shared and species-specific characteristics of DM pathogenesis and treatment, this review advocates a One Health approach toward optimized antidiabetic therapies that benefit human and veterinary medicine. Full article

Microneedles represent an emerging transdermal drug delivery platform offering painless, minimally invasive penetration of the stratum corneum. This study addresses limitations of conventional lidocaine hydrochloride formulations, such as slow onset and poor patient compliance, by developing lidocaine hydrochloride-loaded dissolvable microneedles (LH-DMNs) for rapid local anesthesia. LH-DMNs were fabricated via centrifugal casting using polyvinyl alcohol (PVA) as the matrix material in polydimethylsiloxane (PDMS) negative molds, which imparts high mechanical strength to the microneedles. Biocompatibility assessments showed negligible skin irritation, resolving within 3 min. And drug-loading capacity reached 24.0 ± 2.84 mg per patch. Pharmacodynamic evaluation via mouse hot plate tests demonstrated significant analgesia, increasing paw withdrawal latency to 36.11 ± 1.62 s at 5 min post-application (p < 0.01). The results demonstrated that the LH-DMNs significantly elevated the pain threshold in mice within 5 min, surpassing the efficacy of conventional anesthetic gels and providing a rapid and effective solution for pain relief. These findings validate the system’s rapid drug release and efficacy, positioning dissolvable microneedles as a clinically viable alternative for enhanced transdermal anesthesia. Full article

Veterinary vaccines are essential tools for controlling infectious and zoonotic diseases, safeguarding animal welfare, and ensuring global food security. However, conventional vaccines are hindered by cold-chain dependence, thermal instability, and logistical challenges, particularly in low- and middle-income countries (LMICs). This review explores next-generation veterinary vaccines, emphasizing innovations in thermostability and delivery platforms to overcome these barriers. Recent advances in vaccine drying technologies, such as lyophilization and spray drying, have improved antigen stability and storage resilience, facilitating effective immunization in remote settings. Additionally, novel delivery systems, including nanoparticle-based formulations, microneedles, and mucosal routes (intranasal, aerosol, and oral), enhance vaccine efficacy, targeting immune responses at mucosal surfaces while minimizing invasiveness and cost. These approaches reduce reliance on cold-chain logistics, improve vaccine uptake, and enable large-scale deployment in field conditions. The integration of thermostable formulations with innovative delivery technologies offers scalable solutions to immunize livestock and aquatic species against major pathogens. Moreover, these strategies contribute significantly to One Health objectives by mitigating zoonotic spillovers, reducing antibiotic reliance, and supporting sustainable development through improved animal productivity. The emerging role of artificial intelligence (AI) in vaccine design—facilitating epitope prediction, formulation optimization, and rapid diagnostics—further accelerates vaccine innovation, particularly in resource-constrained environments. Collectively, the convergence of thermostability, advanced delivery systems, and AI-driven tools represents a transformative shift in veterinary vaccinology, with profound implications for public health, food systems, and global pandemic preparedness. Full article

Unrefined psyllium husk derived from Plantago ovata constitutes a complex mixture of water-soluble and insoluble polymeric chains that form an interpenetrating network capable of entrapping carbon nanoparticles. While the resulting composite was found to swell in aqueous electrolyte, it exhibited hydrogel-like properties where the electrochemical activity was retained and found to be stable upon repetitive voltammetric cycling. Planar film systems were characterized by electron microscopy, Raman spectroscopy, tensile testing, gravimetric analysis, contact angle and cyclic voltammetry. A key advantage of the composite lies in its ability to be cast in 3D geometric forms such as pyramidal microneedle arrays (700 μm high × 200 μm base × 500 μm pitch) that could serve as viable electrode sensors. In contrast to conventional composite electrode materials that rely on non-aqueous solvents, the psyllium mixture is processed entirely from an aqueous solution. This, along with its plant-based origins and simple processing requirements, provides a versatile matrix for the design of biodegradable electrode structures that can be manufactured from more sustainable sources. Full article

Microneedles have emerged as a versatile technology for biosensing across biomedical domains and are increasingly being explored for other applications like agriculture. This review highlights recent advancements in the development of microneedle-based biosensors in novel areas. Biomedical applications include continuous glucose monitoring, multiplexed biomarker detection beyond glucose, and numerous recent works presenting fully integrated systems comprising microneedle arrays alongside miniaturized wearable electronics. Agricultural applications largely focus on the detection of plant growth markers, hormones, and nutrient levels. Despite significant progress, challenges remain in overcoming biofouling and electrode degradation, optimizing electrode longevity for long-term (weeks to months) in situ monitoring, and creating scalable sensor fabrication processes. Additionally, there is a need for standardized mechanical and electrical testing protocols, and guidelines specifying critical performance metrics that should be reported to facilitate accurate literature comparisons. The review concludes by outlining key opportunities for future research to address these persisting challenges. Full article

Microneedle (MN)–tissue interactions play a critical role in the efficiency and reliability of transdermal drug delivery and biosensing, yet their mechanistic understanding remains limited. This study systematically investigates the effects of biological (tissue type and temperature) and mechanical (needle design, material, and insertion velocity) parameters on the performance of microneedle insertion and extraction. Experiments were performed on porcine skin, chicken breast, and agarose gel to represent varying tissue properties. Additionally, the effect of tissue temperature on replicating physiological conditions, such as hypo- and hyperthermia, was evaluated using porcine skin as the sample. A novel conical MN design integrated with surface suction-cup structures was developed to improve tissue adhesion. Mechanical responses were analyzed through force–displacement measurements, evaluating insertion force, extraction force, and relaxation time. Results show that elevated tissue temperature reduces insertion and extraction forces while shortening relaxation times, indicating increased tissue compliance. The suction-cup MNs significantly enhanced needle–tissue adhesion, with the most pronounced effect observed in chicken breast tissue, achieving more than a four-fold increase in extraction force compared to conventional conical needles. These findings provide valuable insights into optimizing the design of MNs for advanced biomedical applications. Full article

This study presents the in vitro and preliminary ex vivo development of a novel microneedle-based pH sensor for continuous intrapartum fetal monitoring. The objective was to evaluate the feasibility of using microneedle sensors to monitor fetal pH during labour and to develop a proof-of-principle microneedle pH sensor that meets clinical requirements such as high sensitivity to small pH changes (0.05 units) within a relevant range (6.50–7.45), minimal tissue disruption, and a compact design suitable for transcervical placement on the fetal scalp (<40 mm diameter). Platinum microneedles were passivated with ArCare medical adhesive and coated with iridium oxide via electrodeposition. Sensitivity was tested in phosphate buffered saline (PBS) and artificial interstitial fluid (ISF), using both external Ag/AgCl and internal platinum pseudo-reference electrodes. In PBS, the sensor exhibited linear responses in increments of 0.05 pH units over the clinically relevant range (6.5–7.45), with slopes of −60.49 mV/pH (R² = 0.946, accuracy = 97.65%) and −63.2 mV/pH (R² = 0.910, accuracy = 93.70%) in the external and internal configurations, respectively. In ISF, a slope of −25.5 mV/pH (R² = 0.979) was obtained. Ex vivo testing on human skin confirmed successful microneedle penetration without visible iridium oxide transfer or tissue damage, as indicated by methylene blue staining. These findings support the potential for continuous minimally invasive fetal pH monitoring during labour, representing a significant step toward more objective and specific intrapartum assessment. Full article

Nanocrystals, defined as crystalline particles with dimensions in the nanometer range (<1000 nm), exhibit unique properties that enhance the efficacy of poorly soluble active compounds. This review explores the fundamental aspects of nanocrystals, including their characteristics and various preparation methods, while addressing critical factors that influence their stability and incorporation into final products. A key focus of the review is the advantages offered by nanocrystals in dermal applications. It also highlights their ability to enhance passive diffusion into the skin and facilitate penetration via particle-assisted dermal penetration. Additionally, the review discusses their capacity to penetrate into hair follicles, enabling targeted drug delivery, and their synergistic potential when combined with microneedles, which further enhance the dermal absorption of active compounds. The review also addresses several commercial products that successfully employ nanocrystal technology, showcasing its practical applications. Summary: Nanocrystals with their special properties are an emerging trend for dermal applications, particularly the development of plantCrystals—natural nanocrystals sourced from plant materials—which represent a promising path for future research and formulation strategies. These advancements could lead to more sustainable and effective dermal products. Full article

Colchicine is a potent alkaloid with well-established anti-inflammatory properties. It shows significant promise in treating classic immune-mediated inflammatory diseases, as well as associated cardiovascular diseases, including atherosclerosis. However, its clinical use is limited by a narrow therapeutic window, dose-limiting systemic toxicity, variable bioavailability, and clinically significant drug–drug interactions, partly mediated by modulation of P-glycoprotein and cytochrome P450 3A4 metabolism. This review explores advanced delivery strategies designed to overcome these limitations. We critically evaluate lipid-based systems, such as solid lipid nanoparticles, liposomes, transferosomes, ethosomes, and cubosomes; polymer-based nanoparticles; microneedles; and implants, including drug-eluting stents. These systems ensure targeted delivery, improve pharmacokinetics, and reduce toxicity. Additionally, we discuss chemical derivatization approaches, such as prodrugs, codrugs, and strategic ring modifications (A-, B-, and C-rings), aimed at optimizing both the efficacy and safety profile of colchicine. Combinatorial nanoformulations that enable the co-delivery of colchicine with synergistic agents, such as glucocorticoids and statins, as well as theranostic platforms that integrate therapeutic and diagnostic functions, are also considered. These innovative delivery systems and derivatives have the potential to transform colchicine therapy by broadening its clinical applications while minimizing adverse effects. Future challenges include scalable manufacturing, long-term safety validation, and the translation of research into clinical practice. Full article